News
The Federal Circuit on Tuesday in a precedential decision authored by Judge Taranto affirmed a New Jersey district court’s ...
The herpes simplex virus type 1 (HSV-1), which affects almost two‑thirds of the world's population and is generally ...
A grassroots advocate for medical cannabis at the center of some Nebraska state officials' efforts against the drug is ...
A cancer-killing virus could soon be approved for use after shrinking tumours in a third of people with late-stage melanoma ...
Scientists are developing all sorts of potential new treatments to tackle the most difficult cancer cases—including some that ...
University of Southern California researchers have found a way to rebrand this oft-embarrassing sore subject by genetically modifying HSV-1 and administering it to patients with treatment-resistant, ...
The new policy withdraws the COVID-19 vaccine recommendation for most children and pregnant women made by earlier vaccination policy. Groups suing include the American Academy of Pediatrics, the ...
The REMS program for the ERA drug class was established due to the risk of embryofetal toxicity seen from animal studies.
Interest in the anti-parasitic drug ivermectin skyrocketed during the covid-19 pandemic, but evidence for many of its ...
In recalls, best-by or use-by dates are commonly provided. Even if the affected date has passed, be sure to check your ...
An FDA-funded clinical trial found even modest CBD use triggered elevated liver enzymes in some healthy adults, raising ...
With the clearance, Mendaera is starting a limited launch of Focalist with select medical institutions this year.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results